Somatostatin is increased in the nucleus accumbens in Huntington's disease

scientific article published on May 1, 1984

Somatostatin is increased in the nucleus accumbens in Huntington's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/WNL.34.5.663
P953full work available at URLhttp://journals.lww.com/00006114-198405000-00018
P698PubMed publication ID6143284

P50authorEdward D. BirdQ84176647
P2093author name stringM. F. Beal
P. J. Langlais
J. B. Martin
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectnucleus accumbensQ1476178
Huntington's diseaseQ190564
P304page(s)663-666
P577publication date1984-05-01
P1433published inNeurologyQ1161692
P1476titleSomatostatin is increased in the nucleus accumbens in Huntington's disease
P478volume34

Reverse relations

cites work (P2860)
Q39472153Brain and CSF somatostatin concentrations in patients with psychiatric or neurological illness. An overview
Q52064890Cerebrospinal fluid somatostatin in delirium.
Q54968960Chapter 48 NADPH-Diaphorase-containing neurons and cytochrome oxidase activity following striatal quinolinic acid lesions and fetal striatal transplants
Q82676429Colocalization of somatostatin receptors with DARPP-32 in cortex and striatum of rat brain
Q48634539Depletion of striatal somatostatin by local cysteamine injection
Q49065903Dopamine-somatostatin interactions in the rat striatum: an in vivo microdialysis study
Q48657115Effects of neuroleptic drugs on brain somatostatin-like-immunoreactivity
Q36870168Expression of NMDA Receptor-1 (NR1) and Huntingtin in Striatal Neurons Which Colocalize Somatostatin, Neuropeptide Y, and NADPH Diaphorase: A Double-Label Histochemical and Immunohistochemical Study
Q69896252Lack of effect of chronic carbamazepine on brain somatostatin in the rat
Q45293767NADPH-diaphorase-containing neurons and cytochrome oxidase activity following striatal quinolinic acid lesions and fetal striatal transplants
Q48302663Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease
Q39480436Neuropeptides in neurological disease
Q37167222Neurotransmitter Receptors in Human Brain Diseases
Q42052839Quinolinic acid stimulates somatostatin gene expression in cultured rat cortical neurons
Q43758212Regional distribution of neuropeptide somatostatin gene expression in the human brain
Q34384772Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Q45297003Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease
Q48383936Somatostatin binding sites in human and monkey brain: localization and characterization
Q34017941Somatostatin receptor 1 and 5 double knockout mice mimic neurochemical changes of Huntington's disease transgenic mice
Q48582744Somatostatin-like immunoreactivity in non-pyramidal neurons of the human isocortex
Q90593606The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease
Q48810392The elusive nature of cerebellar somatostatin receptors: studies in rat, monkey and human cerebellum
Q48290477Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease

Search more.